Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer.

R T Oliver1

  • 1London Hospital Medical College, UK.

Current Opinion in Oncology
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Germinal epithelial atrophy is linked to testicular cancer risk and second tumor development. New diagnostic and treatment strategies show promise for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Aphorisms in cancer surgery.

Annals of the Royal College of Surgeons of England·2009
Same author

Prognostic factors for renal cell carcinoma.

Cancer treatment reviews·2008
Same author

Introduction: Clonal evolution in bladder cancer: a scientific and clinical perspective.

Cancer surveys·2004
Same author

Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer.

Cancer surveys·2004
Same author

Malignancy associated papillomaviruses and morphology of human bladder cancer.

Cancer surveys·2004
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Epidemiology
  • Urology

Background:

  • Germinal epithelial atrophy is increasingly recognized as a precursor to testicular cancer.
  • Elevated follicle-stimulating hormone levels correlate with second tumor risk.
  • Vasectomy may be a risk factor for atrophy and testicular cancer.

Purpose of the Study:

  • To review recent advancements in testicular cancer epidemiology, diagnostics, and treatment.
  • To highlight new risk factors and predictive markers.
  • To evaluate current and emerging therapeutic strategies for seminoma and nonseminoma.

Main Methods:

  • Review of epidemiological data and experimental studies on testicular cancer etiology.
  • Analysis of diagnostic approaches, including tumor marker kinetics.

Related Experiment Videos

  • Evaluation of treatment outcomes for stage I nonseminoma and seminoma, comparing chemotherapy and radiotherapy.

    • Main Results:

    • Elevated follicle-stimulating hormone levels predict second tumor risk.
    • Tumor marker rise rate post-orchiectomy identifies drug-resistant disease.
    • Adjuvant chemotherapy for stage I nonseminoma reduces relapse rates.
    • High cure rates for seminoma with chemotherapy; carboplatin shows promise.
    • Adjuvant carboplatin offers an alternative to radiotherapy for stage I seminoma with potentially less toxicity.

    Conclusions:

    • Testicular cancer research is advancing in understanding etiology and risk stratification.
    • Novel diagnostic markers and effective chemotherapy regimens are improving patient outcomes.
    • Chemotherapy is becoming the standard for adjuvant therapy in early-stage testicular cancer, challenging the role of radiotherapy.